Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1/2 1

Status

Unknown 2

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Carcinoma, Non-Small-Cell Lung 234Squamous Cell Carcinoma of Head and Neck 168Head and Neck Neoplasms 141Lung Neoplasms 110Esophageal Neoplasms 109Nasopharyngeal Carcinoma 104Uterine Cervical Neoplasms 101Stomach Neoplasms 88Esophageal Squamous Cell Carcinoma 86Breast Neoplasms 69Urinary Bladder Neoplasms 66Small Cell Lung Carcinoma 58Pancreatic Neoplasms 56Neoplasms 55Carcinoma, Squamous Cell 55Cholangiocarcinoma 52Ovarian Neoplasms 45Neoplasm Metastasis 44Oropharyngeal Neoplasms 43Biliary Tract Neoplasms 41Adenocarcinoma Of Esophagus 35Recurrence 29Mesothelioma, Malignant 28Triple Negative Breast Neoplasms 25Laryngeal Neoplasms 25Nasopharyngeal Neoplasms 24Lymphoma 24Gallbladder Neoplasms 24Sarcoma 21Carcinoma 21

Interventions

Cyclophosphamide 30N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 21Prednisone 20Etoposide 20Vincristine 16Whole-Body Irradiation 15Doxorubicin 15fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 14romidepsin 13Mycophenolic Acid 12Lenalidomide 12Gemcitabine 12Cyclosporine 10Azacitidine 10Brentuximab Vedotin 9Bortezomib 9Alemtuzumab 8Dexamethasone 7Methotrexate 6Cytarabine 6Busulfan 6Carmustine 5pembrolizumab 4fludarabine 4Vorinostat 4Tacrolimus 4Rituximab 4Melphalan 4Ifosfamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Lymphoma, T-Cell, Peripheral × Cisplatin × Clear all
NCT05441761 2022-07-01

Mitoxantrone Hydrochloride Liposomes in Combination With GDP in Relapsed/Refractory PTCL

Peking Union Medical College Hospital

Phase 1/2 Unknown
60 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT03071822 2018-06-11

Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas

The University of Hong Kong

Phase 4 Unknown
50 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡